Also known as Combivent and Ipratropium/Albuterol
The combination preparation ipratropium bromide/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma (not an FDA approved usage). It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent. Besides, it is marketed by Dey, L.P. (Napa, California) under the brand name DuoNeb as a nebulizer. In Italy it is known as Breva.sold in India by cipla as duolinSource: Wikipedia
Estimated Total Cost: $163.78 for an average of 28 days supply
Patients are most commonly prescribed albuterol / ipratropium to treat chronic obstructive pulmonary disease (copd), shortness of breath, asthma, and difficulty breathing.